CCL2 regulated by the CTBP1-AS2/miR-335-5p axis promotes hemangioma progression and angiogenesis

Conclusion: Our findings suggest that targeting the CTBP1-AS2/miR-335-5p/CCL2 axis may hold promise as a therapeutic strategy for HA.PMID:38622049 | DOI:10.1080/08923973.2024.2330651

Source: Immunopharmacology and Immunotoxicology - April 15, 2024 Category: Allergy & Immunology Authors: Ruixuan Li Ying Liu Jianfeng Liu Bo Chen Zhongjie Ji Aixia Xu Tianhua Zhang Source Type: research